Projects_EN Archive

CT M.A.R.S.

September 16, 2022

CT M.A.R.S. CZECH VERSION CLINICAL TRIAL M.A.R.S. M.A.R.S. is a randomized, double-blind, placebo-controlled, multicenter study of the efficacy and safety of highly diluted atropine eye drops in slowing the progression of myopia in children, a phase IIIb, three parallel-arm study designed to increase clinical knowledge of the effect of topical application of highly diluted atropine…
Read more

CT MSC-EB

July 20, 2022

CT MSC-EB CZECH VERSION CLINICAL TRIAL MSC-EB Safety and efficacy of allogenic adipose tissue-derived mesenchymal stromal cells in patients with epidermolysis bullosa: clinical trial phase I/II MSC-EB is a phase I/II clinical trial aiming to evaluate the safety and efficacy of the mesenchymal stromal cell-based medicinal product in patients with the rare congenital (genetic) disease…
Read more

CT KDO_DC1311

July 20, 2022

CT KDO_DC1311 CZECH VERSION CLINICAL TRIAL KDO_DC1311 Combined antitumor therapy with ex vivo manipulated dendritic cells producing interleukin-12 in children, adolescents and young adults with progressive, recurrent or primarily metastatic high-risk tumors KDO_DC1311 is a phase I/II clinical trial aiming to evaluate the safety and efficacy of the dendritic cell-based medicinal product in children, adolescent…
Read more

CT CoVigi

February 16, 2022

CT CoVigi CZECH VERSION CLINICAL TRIAL CoVigi CoVigi is a multi-centre, phase IV post-marketing intervention trial that aims to monitor long-term safety and efficacy after vaccination against COVID-19. The trial was initiated by Masaryk University in cooperation with the University Hospital Brno and the Masaryk Memorial Cancer Institute. A total of 561 patients will be…
Read more

CT DisCoVeRy

February 16, 2022

CT DisCoVeRy CZECH VERSION CLINICAL TRIALS DisCoVeRy A multicenter, adaptive, randomized study of safety and efficacy in hospitalized adult patients with COVID-19. The treatment of COVID-19 is still a major challenge for medical research, so new drugs are being explored or the use of existing drugs is being optimized. One of the new medicines is…
Read more

CT HALF

June 23, 2022

CT HALF CZECH VERSION CLINICAL TRIAL HALF Prospective phase II clinical trial evaluating the efficacy and safety of tyrosine kinase inhibitor discontinuation after prior two-step dose reduction in patients with chronic myeloid leukemia in deep molecular remission The HALF clinical trial is designed as a prospective, multicentre, non-randomized, open-label phase II study to investigate the…
Read more

CT REMED

November 26, 2021

CT REMED CZECH VERSION CLINICAL TRIAL REMED Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomized controlled trial (REMED trial). COVID-19 is still a significant challenge for medical research, exploring new drugs or possible optimizing the use of existing drugs. One way to use an existing medicine is to…
Read more

CT SolidAct

October 16, 2021

CT SolidAct CZECH VERSION CLINICAL TRIAL SolidAct European DisCoVeRy for Solidarity (EU-SolidAct): Clinical study with adaptive platform design for pandemics and new infections Within the platform design, the study follows a generic main protocol, to which a drug-specific sub-protocol is always added. So far, there are two arms in the EU-SolidAct study: 1. Sub-protocol Bari-SolidAct…
Read more

CZECRIN_4 PACIENTY

February 5, 2021

CZECRIN_4 PACIENTYCZECRIN_4 PACIENTY - bringing innovative advanced therapies The main research goal of the project is the development, manufacture and... Realisation period: 1. 7. 2017 - 30. 6. 2021 Registration number: CZ.02.1.01/0.0/0.0/16_013/0001826 Project title: CZECRIN_4 PACIENTY - bringing innovative advanced therapies Beneficiary: St. Anne's University Hospital in Brno Partners: Masaryk University Financed by programme: (OP…
Read more

[18F] -fluorocholin

January 25, 2021

[18F] -fluorocholin[18F] -fluorocholin Radiopharmaceutical, a medicinal product intended for PET/CT scan examination and diagnosis n early stages of prostatic cancer. Clinical trial [18F] -fluorocholin inj was initiated by CZECRIN in cooperation with Masaryk Memorial Cancer Institute (MMCI) Phase I Unit and currently is the product submitted and waiting for registration in Czech Republic. Nejdůležitější odkazy…
Read more